Financière de Tubize SA (EBR:TUB)
Belgium · Delayed Price · Currency is EUR 226.00
+3.40 (1.53%)
Apr 10, 2026, 5:35 PM CET
Financière de Tubize Market Cap
Financière de Tubize has a market cap or net worth of €10.06 billion as of April 10, 2026. Its market cap has increased by 79.37% in one year.
Market Cap
10.06B
Enterprise Value
10.06B
Revenue
n/a
Ranking
n/a
PE Ratio
107.91
Stock Price
€226.00
Market Cap Chart
Since April 16, 2001, Financière de Tubize's market cap has increased from 1.37B to 10.06B, an increase of 633.40%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 10.06B | 8.13% |
| Dec 31, 2025 | 9.30B | 46.98% |
| Dec 31, 2024 | 6.33B | 98.33% |
| Dec 29, 2023 | 3.19B | 1.27% |
| Dec 30, 2022 | 3.15B | -21.59% |
| Dec 31, 2021 | 4.02B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 52.35B |
| argenx SE | 42.41B |
| Onward Medical | 173.63M |
| Hyloris Pharmaceuticals | 134.40M |
| European Medical Solutions | 22.22M |
| Celyad Oncology | 14.10M |
| BioSenic | 1.57M |
| Oxurion NV | 308.43K |